PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18434621-7	2008	Losartan (10(-7) M) and dimethyl-BAPTA-AM (10(-7) M) decreased significantly the stimulatory effect of ANG II (10(-9) M) and induced an increase in Na(+)/H(+) exchanger 1 (NHE-1) activity with ANG II (10(-6) M).	Losartan	0-8	ANG	Canis lupus familiaris	103-106	
30116202-7	2018	In vitro, Ang II induced a decrease in both klotho and in PPAR-gamma in Madin-Darby canine kidney (MDCK) cells, and this effect was blunted by losartan.	Losartan	143-151	ANG	Canis lupus familiaris	10-13	
18434621-7	2008	Losartan (10(-7) M) and dimethyl-BAPTA-AM (10(-7) M) decreased significantly the stimulatory effect of ANG II (10(-9) M) and induced an increase in Na(+)/H(+) exchanger 1 (NHE-1) activity with ANG II (10(-6) M).	Losartan	0-8	ANG	Canis lupus familiaris	193-196	
10409176-9	1999	In the group that received chronic intracerebroventricular infusion of ANG II, the administration of an AT(1)-receptor antagonist losartan (0.125 mg/kg icv) abolished ANG II-induced augmentation of the CSAR.	Losartan	130-138	ANG	Canis lupus familiaris	71-74	
10409176-9	1999	In the group that received chronic intracerebroventricular infusion of ANG II, the administration of an AT(1)-receptor antagonist losartan (0.125 mg/kg icv) abolished ANG II-induced augmentation of the CSAR.	Losartan	130-138	ANG	Canis lupus familiaris	167-170	
8620609-11	1996	The effects in the intact LV and myocytes were reversed by an Ang II AT1 receptor blocker (losartan).	Losartan	91-99	ANG	Canis lupus familiaris	62-65	
7788870-6	1995	The effects of Ang II on IK(Ca) and IK(dr) were inhibited by the specific Ang II receptor antagonist losartan (1 mmol/L, n = 3).	Losartan	101-109	ANG	Canis lupus familiaris	15-18